It functions by inhibiting the growth of tumor cells and the formation of blood vessels through targeting various serine/threonine and tyrosine kinases such as RAF1, BRAF, VEGFR 1, 2, 3, PDGFR, KIT, FLT3, FGFR1, and RET [32]. The gene discussed is BRAF; the disease is neoplasm.